Clinical trials

  • RELUGOLIX for Prostate cancer
  • LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE for Non-ischemic cardiomyopathy
  • NELARABINE for Lung cancer
  • CYCLOSERINE for Major depressive disorder
  • ZIPALERTINIB for Non-small cell lung cancer|Uncommon EGFR-mutated non-small cell lung cancer
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Graves' orbitopathy|Graves' ophthalmopathy
  • KUP-101A for Advanced solid tumours | Cutaneous melanoma | Mucosal melanoma | Cutaneous squamous cell carcinoma | Merkel cell carcinoma | Basal cell carcinoma
  • IVONESCIMAB for Metastatic colorectal cancer
  • Lidocaine hydrochloride for Acute postoperative pain following breast surgery
  • DONANEMAB for Alzheimer's disease | Dementia
  • 8-ETHOXY-N-((3R,4S)-3-METHYL-1-(METHYLSULFONYL)PIPERIDIN-4-YL)-7-(1H-PYRAZOL-4-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-AMINE for Ovarian cancer|Platinum-resistant ovarian cancer
  • Activin signaling inhibitor (specific active substance not stated) for Pulmonary arterial hypertension